Dr. Badr is invested in outstanding medical education. He was the founding director of the WSU Sleep Medicine Fellowship program, and he teaches and mentors students in multiple departments across the medical school.
Dr. Bass’ laboratory has pioneered research on the role of the circadian system in the coordination of behavior & physiology applying genetic approaches to reveal how clocks function within the central nervous system & peripheral tissues to influence sleep, arousal, feeding, & metabolism.
Dr. Dinges’ laboratory has produced an extensive body of federally-funded research on the acute, chronic and cumulative adverse effects of inadequate sleep on human physiological and neurobehavioral functions. His research has influenced policies and practices related to safety and health in the areas of work hours, transportation, defense, and spaceflight.
Dr. Kuna is a clinician researcher who is a member of the Center of Sleep and Circadian Neurobiology at the Perelman School of Medicine at the University of Pennsylvania. He has a joint appointment at the Corporal Michael J. Crescenz Veterans Affairs Medical Center where he serves as Chief of the Sleep Medicine Section and medical director of the VISN 4 Eastern Regional Sleep Center. His research focus is on patient-centered outcomes and novel methods of service delivery.
Most of Dr. Mignot’s current research focuses on the neurobiology, genetics and immunology of narcolepsy, a disorder caused by hypocretin (orexin) cell loss, with indirect interest in the neuroimmunology of other brain disorders. His laboratory uses state of the art human genetics techniques, such as genome wide association, exome or whole genome sequencing in the study of human sleep and sleep disorders, with parallel studies in animal models. His laboratory is also interested in web-based assessments of sleep disorders, computer-based processing of polysomnography (PSG), and outcomes research.
Dr. Rolls studies the connection between the brain and the immune system. By understanding how sleep and defined neuronal affects immunity, her work aims to harness the brain’s therapeutic potential.
Dr. Shellhaas leads a multidisciplinary team for innovative research designed to evaluate quantitative polysomnographic data as markers of risk for adverse neurodevelopmental outcome for newborns who require intensive care. Her related studies have been designed to evaluate the influence of the ICU environment on neonatal sleep and the prevalence of sleep-disordered breathing among newborns who require intensive care.
His research focuses on the circadian and homeostatic regulation of sleep, using both fruit flies and mice as model systems. His group uses high-throughput screens in fruit flies to identify novel genes and circuits involved in these processes and then seeks to examine their relevance for mammals, including humans, by studying them in mice.